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The innate immune system protects against infections by ini-
tiating an inducible inflammatory response. NF-B is one of the
critical transcription factors controlling this complex response,
but some aspects of its regulation remain unclear. For example,
although long non-coding RNAs (lncRNAs) have been shown to
critically regulate gene expression, only a fraction of these have
been functionally characterized, and the extent to which
lncRNAs control NF-B expression is unknown. Here, we
describe the generation of a GFP-based NF-B reporter system
in immortalized murine bone marrow–derived macrophages
(iBMDM). Activation of this reporter, using Toll-like receptor
ligands, resulted in GFP expression, which could be monitored
by flow cytometry. We also established a CRISPR/Cas9 gene
deletion system in this NF-B reporter line, enabling us to
screen for genes that regulate NF-B signaling. Our deletion-
based approach identified two long intergenic non-coding
(linc)RNAs, lincRNA-Cox2 and lincRNA-AK170409, that con-
trol NF-B signaling.We demonstrate a potential novel role for
lincRNA-Cox2 in promoting IB degradation in the cyto-
plasm. For lincRNA-AK170409, we provide evidence that this
nuclearly-localized lincRNA regulates a number of inflamma-
tion-related genes. In conclusion, we have established an NF-
B–GFP iBMDMreporter cell line and a line that stably expresses
Cas9. Our approach enabled the identification of lincRNA-Cox2
and lincRNA-AK170409 asNF-B regulators, and this tool will be
useful for identifying additional genes involved in regulating this
transcription factor critical for immune function.
It is now appreciated that themajority of the human genome
(85%) is actively transcribed, yet less than 3% encodes for pro-
tein-coding genes (1). lncRNAs2 represent the largest group of
RNAsproduced from the genome and are defined as transcripts
greater than 200 nucleotides in length, lacking protein-coding
capacity (2). GENCODE version 24 has 16,000 annotated
lncRNAs within the human genome, yet only 1% of these has
been functionally characterized. From those that have been
characterized, it is clear that lncRNAs are able to function
through a variety of mechanisms to regulate gene expression
(3).
Macrophages are important innate immune cells that func-
tion to recognize and defend against pathogens, while also
helping to promote development of effective adaptive immune
responses (4). Membrane-bound Toll-like receptors (TLRs)
play a critical role in recognizing specific pathogen-associated
molecular patterns initiating a complex inflammatory signaling
cascade culminating in the activation of transcription factors,
including NF-B (5). NF-B, in turn, specifically activates
numerous inflammatory genes, which function to provide pro-
tection against invading microbes. Although NF-B activation
is critical for eliminating pathogens, excess activation of this
pathway can result in a variety of inflammatory-based diseases.
CRISPR/Cas9 technology has revolutionized the field of
functional genomics by providing a novel tool for interrogating
gene function. CRISPR/Cas9 is a deoxyribonuclease (DNase)
that can be specifically targeted to genomic regions via a guide
RNA (gRNA) (6, 7). Targeting of Cas9 to a region results in a
blunt double-stranded DNA break yielding small deletions in
the repaired sequence (8). Small deletions are appropriate for
disrupting open reading frames (ORFs) of protein-coding genes
but are insufficient for disrupting lncRNAs that can be tens of
thousands of kilobases in length (9). Using 5- and 3-flanking
gRNAs, large stretches of DNA can be deleted, allowing for
efficient disruption of lncRNA-encoding loci (10).
Here, we describe a novel NF-B–GFP reporter system in
murinemacrophages combinedwithCRISPR/Cas9 capabilities
to allow robust interrogation of novel lncRNAs involved in
TLR/NF-B signaling. We utilize Cas9-mediated deletion of
candidate lncRNA loci and characterize two lncRNAs, lin-
cRNA-Cox2 and lincRNA-AK170409, and demonstrate their
role in NF-B signaling.We show that although both lincRNAs
alter NF-B signaling, they likely function in distinct ways. We
provide evidence that lincRNA-Cox2 affects IB degrada-
tion in the cytoplasm, whereas nucleus-restricted lincRNA-
AK170409 regulates numerous inflammation-related genes by
modulating other steps of NF-B activation. Here, we estab-
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lished an NF-B–GFP iBMDM reporter cell line with Cas9
capabilities, allowing for rapid screening of novel regulators of
the NF-B pathway. Our characterization of lincRNA-Cox2
and lincRNA-AK170409 serves as an example of how screen-
ing-based identification of novel genes can lead to additional
mechanistic understanding of ways to regulate NF-B.
Results
Development of an NF-B–GFP reporter system inmurine
macrophages
Numerous fluorescence and chemiluminescence-based
NF-B reporters have been developed in a variety of cell lines
(11, 12), which have facilitated the identification of novel genes
involved in regulating NF-B activity. Until recently (13), no
fluorescent-based NF-B reporter systems had been described
in bonemarrow–derivedmacrophages (BMDMs). BMDMs are
criticalmediators of the inflammatory response and represent a
more physiologically relevant cell line compared with other
reporters currently available. We constructed a GFP-based
NF-B reporter system by adding 5 NF-B-binding motifs
(GGGAATTTCC) upstream of the minimal CMV promoter-
driven GFP (Fig. 1A). Immortalized BMDMs (iBMDMs)
were lentivirally infected and clonally selected for optimal
reporter activity. We tested the utility of our system by stim-
ulating cells with various TLR ligands for 6, 24, or 48 h (Fig.
1, B and C). Stimulated cells showed 10-fold induction of
GFP for LPS (Tlr4), Pam3CSK4 (Tlr1/2), and R848 (Tlr7/8),
while showing weak induction with poly(I:C) (Tlr3) ligand
(Fig. 1, B and C). We confirmed that the NF-B reporter cells
were capable of inducing endogenous proinflammatory
genes Il6 and Ccl5 (Fig. 1D). Together, these data show that
we have developed a functional GFP-based NF-B reporter
system in macrophages.
Demonstration of CRISPR/Cas9 functionality in the
NF-B–GFP cells
One the most useful features of NF-B reporter systems has
been the ease of use for screen-based identification of genes
that regulate the NF-B pathway (14). CRISPR/Cas9 technol-
ogy has revolutionized the field of functional genomics by pro-
viding a novel tool for interrogating gene function. We recon-
stituted the CRISPR/Cas9 system into our reporter cells using
lentiviral transduction, allowing a versatile and easy way to
interrogate novel gene function (supplemental Fig. S1A). Cas9
has been observed to have unwanted toxicity in cells (15).
Nevertheless, we confirmed that Cas9 expression did not
alter the function of our NF-B reporter system (supplemen-
tal Fig. S1). To validate the CRISPR/Cas9 system, we cloned
three gRNAs targeting Tlr4 or non-targeting (NT) guides
into a U6-gRNA lentiviral construct and infected Cas9-ex-
pressing iBMDM cells for 7 days to allow for complete edit-
ing of the target genes. LPS stimulation of the NT-expressing
cells resulted in10-fold induction of GFP as expected (Fig.
2A, row i, blue). In contrast, anti-Tlr4 guide-expressing cells
were not able to induce GFP upon LPS stimulation (Fig. 2A,
rows ii–iv, black). We confirmed the specificity of the anti-
Tlr4 guides by demonstrating that Tlr2 stimulation was not
altered (Fig. 2B, rows ii–iv, black). Quantifications of mean
fluorescence intensities for two representative experiments
are shown in Fig. 2, C (LPS) and D (P3C4). Together, these
data demonstrate that we have successfully constructed an
NF-B reporter system in iBMDMs with functional Cas9
capabilities.
Using deletion-based screening to identify lncRNAs important
in regulating NF-B
We have previously performed RNA sequencing on mu-
rine iBMDMs following stimulation with the Tlr1/2 ligand
Pam3CSK4, andwe identified 64 up-regulated lncRNAs follow-
ing stimulation (16). From the data set, 20 of the lncRNAs were
intergenic, meaning they possessed their own promoters and
did not overlap any protein-coding genes, which allowed for
deletion of loci without potential disruptions to neighboring
coding genes. To select candidates for deletion, we focused
on the highly up-regulated lincRNAs that overlap both our
data (16), as well as the dataset generated by Lam et al. (17)
where they stimulated cells with Pam3CSK4 and LPS. From
these data, we focused our attention on lincRNA-Cox2
and lincRNA-AK170409. The expression profile of these
lncRNAs supported that they were likely regulated by the
NF-B via TLR-signaling pathway; however, whether these
lncRNAs were involved in regulating NF-B has not been
investigated.
We had previously established a role for lincRNA-Cox2 in
regulating immune response genes (16). Knocking down lin-
cRNA-Cox2 in murine iBMDMs using shRNA led to a reduc-
tion in expression of proinflammatory genes such as Il6 (16),
although the mechanism by which lincRNA-Cox2 regulates
these genes remains unclear. Here, we delete the lincRNA-
Cox2 locus using CRISPR/Cas9 to directly test the impact on
NF-B signaling. We designed two gRNAs targeting both 5-
and 3-sequences flanking the lincRNA-Cox2 locus (Fig. 3A,
red arrows). We isolated a clone containing a deletion in the
locus and verified the loss of lincRNA-Cox2 expression by
qPCR (Fig. 3B). We have previously shown that expression of
lincRNA-Cox2 is most highly induced by TLR stimulation
peaking at 5 h, and here we confirm this is also true in our
iBMDM reporter system (Fig. 3B). We have also previously
reported that lincRNA-Cox2 is directly regulated by F-B
binding (17). A small number of NF-B-induced lncRNAs have
been demonstrated to function as positive/negative feedback
regulators of NF-B signaling (3). It was unclear whether lin-
cRNA-Cox2 played this type of role. In this study, we found that
disruption of the lincRNA-Cox2 locus leads to an overall
decrease in NF-B activity when cells were stimulated with a
variety of ligands at both 24 h (Fig. 3C) and 48 h (Fig. 3D)
post-stimulation. Induction of Il6 was diminished in the KO
cells at the 5-h time point (Fig. 4E), whereas Tnf, which is most
highly induced after 2 h of stimulation, was not altered (Fig. 4F).
These data are consistent with our previous study using shRNA
where we showed that lincRNA-Cox2 can affect genes at the
level of transcription (16). Inducible activation of NF-B
depends upon proteosomal degradation of the inhibitor of
NF-B proteins (IBs), which retains inactive NF-B dimers in
the cytosol (18). Surprisingly, we found that there was a dra-
matic decrease in IB degradation following 0.5 h of stimula-
CRISPR/Cas-based screening of lncRNAs in NF-Bmacrophages
20912 J. Biol. Chem. (2017) 292(51) 20911–20920
Figure 1. NF-B–GFP reportermacrophages can respond to various Tlr ligands. A, immortalized BMDMswere infectedwith the NF-B reporter construct
containing 5NF-B-binding sites upstream of aminimal promoter GFP. B, iBMDMswere either not stimulated (red) or stimulated with LPS (Tlr4), Pam3CSK4
(Tlr1/2), R848 (Tlr7/8), or poly(I:C) (Tlr3) ligands (blue) for the indicated hours. At the indicated times, cells were analyzed by FACS to assess induced GFP levels.
C, histograms from B are summarized in bar format. D, Il6 and Ccl5 mRNA levels were assessed by qPCR via normalization to the housekeeping gene Gapdh.
Results are presented as mean S.D. for at least three replicate experiments.
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Figure 2. Validation of CRISPR/Cas9 system functionality in NF-B–GFP reporter macrophages. iBMDM NF-B–GFP-Cas9 cells were infected with anti-
Tlr4gRNAsor negative control gRNA lentivirus andpuro-selected toobtainpuregRNA-expressing cells.A andB, after 24hof no-stimulation (red) or stimulation
with either LPS (A) or Pam3CSK4 (B) (blue), GFP inductionwas assessedby FACS.Row i represents cells infectedwithNT, stimulated (blue) or no stimulation (red),
and rows ii–iv show Tlr4g1, Tlr4g2, or Tlr4g3, respectively, stimulated (black) or no-stimulation (gray). C and D, histogram data from A and B are summarized in
bar format for either LPS (C) or P3C4 (D) stimulation. Results are presented as mean S.D. from duplicate experiments.
CRISPR/Cas-based screening of lncRNAs in NF-Bmacrophages
20914 J. Biol. Chem. (2017) 292(51) 20911–20920
tion with LPS in the lincRNA-Cox2 KO cells (Fig. 3, G and H).
The NF-B subunit p65 has been shown to directly regulate
IB levels (19). Hence, one explanation for the deficiency in
IBdegradation could be explained by alterations in p65 levels
(19). We measured p65 RNA levels by qPCR in the control and
KOcells and foundnodifference at the basal levels (supplemen-
tal Fig. S2), although there was a decrease in p65 levels at 5 h
post-stimulation in the KO cells (supplemental Fig. S2). IB is
localized to the cytoplasm, whereas lincRNA-Cox2 has been
shown to be localized to both the nucleus and cytoplasm (Fig.
4C) (16). Our data support a possible role for lincRNA-Cox2 in
the cytoplasm regulating the degradation of IB. IB degra-
dation occurred at 0.5 h post-stimulation, which suggests that
basal cytoplasmic expression of lincRNA-Cox2 could impact
theNF-Bpathway; however, themechanismof action remains
to be determined. Here, we have established the utility of our
Figure 3. Deletion of lincRNA-Cox2 disrupts NF-B signaling. A, schematic shows location of targeting by two gRNAs (red arrow), targeting upstream and
downstreamof the lincRNA-Cox2 locus. B, expression levels of lincRNA-Cox2were assessed for control and KO cells by qPCR for indicated time points. C andD,
mean fluorescence induction of GFPwas assessed by FACS for control and KOBMDMs after LPS, P3C4, or R848 stimulation for 24 h (C) or 48 h (D). E and F, qPCR
was used to assess mRNA expression levels for Il6 (E) and Tnf (F) for the indicated time points. G,Western blot analysis for IBwas performed for control (Ctl)
and KO for indicated time points following LPS stimulation.H, quantitations of theWestern blot fromG are shown. All qPCR datawere performed in biological
triplicates and normalized to Gapdh. *, p 0.05; **, p 0.01; ***, p 0.005.
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NF-B–Cas9 system for deletion-based screening for lncRNAs
involved in NF-B signaling.
lincRNA-AK170409 is a novel regulator of NF-B signaling
Given that a only a small number of NF-B-induced
lncRNAs have been demonstrated to function as positive and
negative feedback regulators of NF-B signaling, we reasoned
that there could be other novel regulators of this pathway (3).
We targeted the intergenic lincRNA-AK170409 because it
showed high induction with LPS and Pam3CSK4 in both pri-
mary macrophages and in our iBMDMs reporter cells (Fig. 4A,
LPS and P3C4). Additionally, this lincRNA possesses an induc-
ible ChIP peak for transcription factor c-Jun (17), a component
of the AP-1 transcription complex with roles in inflammation
(Fig. 4A, c-Jun) (20). To determine the precise expression kinet-
ics for this lincRNA, we performed qPCR on iBMDMs stimu-
lated with LPS for 0, 2, 5, and 24 h (Fig. 4B).The lincRNA-
AK170409 expression peaked at 2 and 5 h and was reduced by
24 h post-stimulation (Fig. 4B). lncRNAs can be found in both
the nucleus and cytoplasm. We examined the cellular localiza-
tion of lincRNA-AK170409 and determined that it was local-
ized strictly to the nucleus (Fig. 4C). In the samemanner as was
used for lincRNA-Cox2, we designed two gRNAs targeting the
5 and 3 of the AK170409 locus (Fig. 4D, red arrows). We elec-
troporated gRNAs into iBMDMs, performed limited dilution
isolation of clones, and screened for deletion containing clones.
Using lincRNA-AK170409-specific genotyping primers (Fig.
4D), we confirmed deletion of one allele of the AK70409 locus
(Fig. 4, E and F), which resulted in 50% reduction in lincRNA
expression, as evaluated by qPCR (Fig. 4G). We screened over
300 clones and failed to identify a clonewith both alleles deleted
suggesting that knocking out this lincRNA could be lethal to
cells. Nevertheless, reduced expression of lincRNA-AK170409
resulted in a significant reduction in NF-B signaling following
stimulation with either LPS or Pam3CSK4, which suggests a
role for this lincRNA in the pathway (Fig. 4,H and I). Unlike the
data observed for lincRNA-Cox2, we found no difference in
IB degradation between control and heterozygote cells (Fig.
4, J and K) suggesting that the effects of this lincRNA are on a
different part of the pathway. To assess global gene expression
changes that result from deletion of the AK170409 locus, we
performed Nanostring analysis on control and heterozygote
iBMDMs stimulated for 2 and 5 h (Fig. 4, L andM, and supple-
mental Tables S1 and S2). Interestingly, we identified genes that
were both up- and down-regulated when lincRNA-AK170409
was knocked down, including genes with known roles in the
TLR-signaling pathway (Fig. 4, L and M, and supplemental
Tables S1 and S2). Intriguingly, one of themost down-regulated
genes was the aryl hydrocarbon receptor (Ahr) gene, which
encodes a ligand-activated transcription factor known to regu-
late immune responses (discussed below) (21). Genes affected
by knockdown of lincRNA-AK170409 were highly correlated
between the 2- and 5-h time points (Fig. 4N). Together, by using
our NF-B–Cas9 system, we have identified two new lincRNAs
that control NF-B signaling, and we demonstrated that this
system is a versatile tool for coding and non-coding gene
interrogation.
Discussion
Here, we developed a new fluorescence-based NF-B re-
porter system in iBMDMs. We have enabled CRISPR/Cas9
capabilities and demonstrated proof-of-concept utility of the
system for screening novel regulators of the NF-B pathway.
Furthermore, we utilized the system to identify two novel
lncRNAs that regulate the NF-B pathway.
We have identified lincRNA-Cox2 and lincRNA-AK170409
as twonovel regulators ofNF-B.Wehave previously identified
lincRNA-Cox2 as a critical regulator of immune response genes
(16). Knocking down lincRNA-Cox2 resulted in reduced
expression of proinflammatory genes such as Il6, whereas inter-
feron-stimulated genes (ISG)were up-regulated (16). lincRNA-
Cox2 is expressed in both the nucleus and cytoplasm and had
previously been shown to regulate ISGs through its interaction
with the nuclearly-localized Hnrnpa2/b1 and a/b proteins (16).
Until now, we did not understandwhat factors were involved in
lincRNA-Cox2’s regulation of Il6. Fromour previous studieswe
knew lincRNA-Cox2 is directly induced by NF-B binding,
which also activates Il6 (16). It was unclear whether lincRNA-
Cox2 was involved in positive/negative feedback to impact
NF-B activity. Here, we show that lincRNA-Cox2 deletion
directly reduces NF-B activity, which suggests a novel role for
lincRNA-Cox2 as an NF-B cofactor required for maximal
activity. A recent study by Hu et al. (22) demonstrated that
lincRNA-Cox2 mediates activation of late-primary response
genes by facilitating recruitment ofNF-B subunits to the SWI/
SNF chromatin-remodeling complex. This study reported no
global inhibition of NF-B activity in lincRNA-Cox2-depleted
cells, demonstrating no change in IB degradation or p65
translocation (22). Like Hu et al. (22), we find that although
NF-B is reduced in our reporter system, not all NF-B down-
stream genes are affected by knocking out lincRNA-Cox2. For
example, we confirm that Il6 is reduced in our cells following
Cas9 removal of lincRNA-Cox2; however, Tnf expression
remains intact. Interestingly, Il6 requires remodeling by the
Figure4.Deletionofanovel lincRNA locus results indisruptionofNF-Bsignaling.A,UCSCgenomebrowser tracks showing the lincRNA-AK170409 locus,
Gro-seq data, c-Jun transcription factor binding, and transcriptional induction of the locus by LPS and P3CSK4 ligands. B, expression levels of lincRNA-
AK170409 were assessed following stimulation with LPS for the indicated hours (hrs). C, nuclear/cytoplasmic subcellular fractionation of LPS-stimulated cells
was performed, RNA was extracted, and qPCR was done for the indicated genes. Actin (Actb) mRNA is a cytosol-localized control, whereas Neat1 serves as a
nuclearly-localized control. D, schematic shows location of targeting by two gRNAs (red arrow), targeting upstream and downstream of the AK170409 locus.
Binding position of genotyping primers is shown for primer sets 1 and 2. E, amplicons for primer sets 1 and 2 were resolved on an agarose gel. Primer set 1
amplicon, only produced from AK170409 deleted alleles (white dash line), was sequenced and aligned to the mouse genome in F. G, expression levels of
AK170409were assessed for Ctl andheterozygote (Het) cells by qPCR following stimulationwith LPS.H and I, mean fluorescence inductionofGFPwas assessed
by FACS for Ctl and Het cells after 24 h of stimulation with LPS (H) or Pam3CSK4 (I). J,Western blot analysis for IBwas performed for Ctl and Het cells for the
indicated hours (hrs) post-LPS stimulation. K, quantitation of the Western blot from J are shown. L andM, volcano plots display differentially expressed genes
in Het versus Ctl iBMDM stimulatedwith LPS for 2 h (L) or 5 h (M).N,mean fold changes for the 2 and 5 hwere plot against each other. R2 value is calculated. All
qPCR data were performed in biological triplicates and normalized to the housekeeping gene Gapdh. *, p 0.05; **, p 0.01; ***, p 0.005.
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SWI/SNF complex, whereas Tnf, which is an immediate early
gene, does not. In contrast to the Hu et al. (22) study, we
observed a dramatic decrease in IB degradation in the cyto-
plasm of lincRNA-Cox2 knock-out cells following LPS stimu-
lation. This observation was especially intriguing because we
do not see all NF-B-dependent genes down-regulated. We
hypothesize the low level of IB degradation observed in the
lincRNA-Cox KO cells may still allow normal Tnf induction at
the 2-h time point. These data provide the first insight into a
possible role for lincRNA-Cox2 in the cytoplasm. lincRNA-
Cox2 is expressed at basal levels in cells and is highly expressed
at 5 h post-LPS stimulation. Because the defect in IB degra-
dation is occurring very early (0.5 h) post-stimulation, we
believe basal expression of lincRNA-Cox2 must be important
for controlling the pathway. Although the exact mechanism of
how lincRNA-Cox2 regulates Il6 remains to be determined, its
clear that lincRNA-Cox2 promotes degradation of IB, which
likely contributes to optimal activation of Il6. Further studies
will be needed to obtain a more complete understanding of all
the complex parts that contribute to NF-B signaling.
lincRNA-AK170409 is a previously uncharacterized lincRNA.
We identified it from RNA-sequencing data as a highly up-reg-
ulated lncRNA in iBMDMs following LPS and Pam3CSK4
stimulation. Kinetic expression analysis revealed that this lin-
cRNA is induced as early as 2 h post-stimulation and subsides
by 24 h, which is a gene expression pattern characteristic of
inflammatory related genes. lncRNAs have been demon-
strated to have roles in both the nucleus and cytoplasm. As
lincRNA-AK170409 is strictly nuclearly localized, this suggests
its modulation of NF-B activity is likely occurring in the
nucleus. We directly assessed changes in gene expression as a
result of an50% decrease in lincRNA-AK170409 expression.
We identified genes with known roles in TLR signaling, includ-
ing Irak2 and Tirap. One of the genes most drastically down-
regulated (100-fold) in lincRNA-AK170409 knockdown cells
is the aryl hydrocarbon receptor (Ahr) gene, which encodes a
ligand-activated transcription factor known to function in con-
cert with NF-B to regulate immune response genes (23).
Expression of Ahr expression requires binding of the NF-B
subunit, RelA (p65) (21), and it has been shown tomodulate the
expression of genes, including Il6 in the context of lung cancer
(24). Interestingly, the activation of Ahr mirrors that of p65 in
that Ahr is normally retained in the cytoplasm and relocates to
the nucleus upon specific stimulants (25). Stimulants that acti-
vate Ahr include numerous hydrocarbon-based air pollutants,
which are implicated in promoting low-grade chronic inflam-
mation in the lungs (26). In conclusion, these data demonstrate
that lincRNA-AK170409 is a regulator of NF-B in iBMDMs.
Further studies will be needed to determine the exact mecha-
nism bywhich this lincRNA regulates the numerous inflamma-
tory related genes identified in this study.
There are currently a wide variety of NF-B reporters
commercially available, including luciferase-based assays and
secreted alkaline phosphatase reporter assays, which are recon-
stituted in a variety of cell types. A recent study described a
p65-EGFP fusion and Tnf promoter reporter systems in mouse
macrophages, highlighting the tremendous advantage of using
reporter systems to dissect complex immunological pathways
(13). Here we combine a robust NF-B–GFP reporter system
with CRISPR/Cas9 capabilities into macrophages, an impor-
tant cell type in the inflammatory immune response. Our
reporter system is fully compatible and was intentionally
designed for use in high-throughput FACS-based CRISPR
screens. Hence, unlike the p65-GFP and Tnf reporter systems
that require microscopy-based screening methods, our system
opens the possibility of performing FCS-based pooled screens
on tens of thousands of genes simultaneously similar to pub-
lished screens in other cell lines (27). Furthermore, ourNF-B–
Cas9 iBMDM system offers the ability for functional dissection
of pathways involved in the “priming” steps of the inflammatory
response from the downstream inflammasome program.
Macrophages are critical effectors of the inflammatory re-
sponse necessary for eliminating a variety of pathogens and
maintaining homeostasis. Paradoxically, macrophages are also
the cell type of choice for infection and replication of many
distinct bacteria and viruses (28). Our system offers the ability
to explore genes involved in pathogen replication, with the abil-
ity to dissect pathways specifically involved in NF-B activa-
tion. In conclusion, we have generated a new NF-B–GFP
iBMDM reporter line, as well as a line stably expressing active
Cas9. These cells will be useful for researchers interested in
conducting pooled based screening, which could be used to
identify novel genes involved in regulating NF-B in response
to infection or could be used for drug discovery screening. Here
we utilized the system to identify lincRNA-Cox2 and lincRNA-
AK170409 as novel regulators of NF-B.
Experimental procedures
Cell culture and stimulation
Bone marrow cells from wild-type mice were cultured in
DMEM with 10% fetal bovine serum, 100 units/ml penicillin,
100 g/ml streptomycin (Sigma), and 20% L929 supernatants
to generate BMDMs. BMDMs were immortalized with J2 virus
to generate iBMDMs. Cells were stimulated for the indicated
times with LPS (Tlr4) (100 ng/ml), Pam3CSK4 (Tlr2/1) (100
nM), Pam2CSK4 (Tlr2/6) (100 ng/ml), and poly(I:C) (Tlr3) (25
g/ml) (Sigma).
Plasmids and cloning
The NF-B reporter construct was made by cloning five
NF-B-binding sites into the pLSmP vector via PvuII/SbfI as
described previously (29). The Cas9 construct was constructed
from a pSico lentiviral backbone with an EF1a promoter
expressing T2A flanked genes: blastocidin-resistant (blast),
blue fluorescent protein, and humanized Streptococcus pyo-
genesCas9 (Fig. 2A). The gRNA construct was also constructed
from a pSico lentiviral backbone driven by an EF1a promoter
expressing T2A flanked genes: puro and cherry. gRNAs were
expressed from amouse U6 promoter. 20-Nucleotide forward/
reverse gRNAoligonucleotideswas annealed and cloned via the
AarI site.
NF-B-CRISPR/Cas9 cell line construction and validation
iBMDMs were infected with the NF-B reporter construct
and clonally selected to maximize NF-B–GFP induction.
CRISPR/Cas-based screening of lncRNAs in NF-Bmacrophages
20918 J. Biol. Chem. (2017) 292(51) 20911–20920
These cells were lentivirally infected with the Cas9 construct
(described above) and were selected by blastocidin for 2
weeks to obtain Cas9-expressing cells (validated byGFP knock-
down). These Cas9-expressing cells were then infected with
either Tlr4 or non-targeting gRNA-expressing virus and were
puromycin selected for 1 week, before assaying effects on
the NF-B reporter. Tlr4 gRNA sequences and lincRNA-
AK170409 and lincRNA-Cox2 targeting gRNAs are also shown
in Table 1.
Cell extracts andWestern blottings
Cell lysateswere prepared inHigh Stringency Lysis buffer (50
mM HEPES, pH 7.5, 100 mM NaCl, 1 mM EDTA, 1% Nonidet
P-40, 10% glycerol) containing protease inhibitor mixture
(Roche Applied Science) and quantified by the bicinchoninic
acid (BCA) assay (Thermo Fisher Scientific). Where indicated,
the NE-PER kit (Thermo Fisher Scientific) was used for cellular
fractionation prior toWestern blotting or analysis by RT-PCR.
Equivalent masses (15 g) of each sample were resolved by
SDS-PAGE and transferred to a polyvinylidene difluoride
(PVDF) membrane and Western-blotted with IB (1:1,000;
Cell Signaling). Horseradish peroxidase-conjugated -actin
monoclonal antibody (1:5,000, Santa Cruz Biotechnology) was
used as loading control. HRP-conjugated goat anti-mouse
(1:10,000, Bio-Rad) or anti-rabbit (1:10,000, Bio-Rad) second-
ary antibodies were used. ImageJ (http://rsbweb.nih.gov/ij/)
was used for quantification of Western blottings.
RNA extraction, real-time PCR, and Nanostring analysis
iBMDMs (2e6 cells/condition) were stimulated for the indi-
cated number of hours. RNA was extracted using the Direct-
zolTM RNAMiniPrep kit (Zymo Research), and 1mg of total or
nuclear RNAwas used for cDNA synthesis. RNAwas extracted
from infected BMDMs at the indicated time points using the
iScript Select cDNA synthesis kit (Bio-Rad), and quantitative
RT-PCR analysis was performed with the primers listed in the
tables. iBMDMswere stimulated with LPS, in triplicate, for 2 or
5 h. RNA was extracted as described above, and 100 ng of total
RNA was hybridized to the nCounter Mouse Immunology
Gene Expression Codeset per the manufacturer’s instructions
and then quantified on an nCounter machine (Nanostring).
Differential expression was determined using standard DEseq2
analysis. RT-PCR primer sequences are in Table 2.
Genotyping
GenomicDNAwas extracted from iBMDMs (1e6 cells) using
Chelex supplemented with Tween 20 (Thermo Fisher Scien-
tific) and proteinase K (Thermo Fisher Scientific) and incu-
bated at 50 °C for 1 h. PCR was run with 1l of the Chelex mix,
genotyping primers (0.5 M), and 2 KAPA-TAQ master mix
(KAPABiosystems) using the standardPCRprotocol. Indicated
PCR product (1F/R) was gel-purified and topo-cloned (Thermo
Fisher Scientific) to allow for standard Sanger sequencing.
Genotyping primer sequences are in Table 3.
Statistics
Statistical significance of differences across two experimen-
tal groups was calculated using unpaired, two-tailed Student’s t
test in GraphPad Prism 6.0 software.
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and coordinated the study and wrote the paper. E. K. R., S. Car-
penter, and S. Covarrubias performed FACS-based experiments
throughout the paper. S. K. processed the nanostring data by DEseq
analysis. B. S. and E. K. R. performed Western blot analysis. N. H.
and N. F. performed the limited dilution screening that led to the
identification of the AK170409 heterozygote clone. S. Covarrubias,
S. Carpenter, A. V. and E. K. R. provided technical assistance and
contributed to the preparation of the manuscript and figures.
M. T. M. provided critical reagents and suggestions. All authors
reviewed the results and approved the final version of the
manuscript.
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